Serum Galectin-1, Galectin-9, and YKL-40 levels in bipolar disorder and their relationship with cognitive functions
- PMID: 38346720
- PMCID: PMC10861353
- DOI: 10.1002/brb3.3421
Serum Galectin-1, Galectin-9, and YKL-40 levels in bipolar disorder and their relationship with cognitive functions
Abstract
Purpose: The number of studies conducted on the role of neuroinflammation in the etiopathogenesis of bipolar disorder has been increasing in recent years. The role of Galectin-1, Galectin-9, and YKL-40, which are considered to play roles in neuroinflammation and the etiopathogenesis of bipolar disorder, and the relationship of these parameters with cognitive functions were investigated in the present study.
Method: Serum Galectin-1, Galectin-9, and YKL-40 levels were measured with the ELISA Method in 64 bipolar euthymic patients and 64 healthy controls. The Stroop and trail-making tests were administered to assess cognitive functions in all participants.
Results: Serum Galectin-1, Galectin-9, and YKL-40 levels were statistically and significantly lower in the patient group when compared to the healthy control group. The scores of the Stroop test and trail-making tests were statistically higher in the patient group than in the healthy control group. There was a weak and positive correlation between serum Galectin-1, Galectin-9, and YKL-40 levels and cognitive performance in all participants.
Discussion and conclusion: Statistically significant low levels of serum Galectin-1, Galectin-9, and YKL-40 detected in the patient group suggest that these parameters have important roles in neuroinflammation. The statistically higher Stroop and trail-making test scores of the patient group compared to the control group indicates that the cognitive performance of the patient group was weaker. Also, the positive correlation between Galectin-1, Galectin-9, and YKL-40 levels and cognitive performance suggests that these molecules may have a neuroprotective role. We think that the present study will contribute to this field where there is very limited data in the literature.
Keywords: Galectin-1; Galectin-9; YKL-40; bipolar disorder; cognitive functions; inflammation; neuroinflammation.
© 2024 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Conflict of interest statement
All of the authors declare that there are no conflicts of interest in connection with this paper.
Similar articles
-
CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment.Eur Neuropsychopharmacol. 2015 Aug;25(8):1091-8. doi: 10.1016/j.euroneuro.2015.04.023. Epub 2015 May 5. Eur Neuropsychopharmacol. 2015. PMID: 26024928
-
Cerebrospinal Fluid Biomarkers of Central Nervous System Inflammation Predict Cortical Decline in Bipolar Disorder and Ventricular Enlargement in Healthy Controls.Neuropsychobiology. 2025;84(1):38-47. doi: 10.1159/000542888. Epub 2024 Dec 3. Neuropsychobiology. 2025. PMID: 39626639 Free PMC article.
-
Tryptophan breakdown and cognition in bipolar disorder.Psychoneuroendocrinology. 2017 Jul;81:144-150. doi: 10.1016/j.psyneuen.2017.04.015. Epub 2017 Apr 27. Psychoneuroendocrinology. 2017. PMID: 28482311
-
The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC).Bipolar Disord. 2010 Jun;12(4):351-63. doi: 10.1111/j.1399-5618.2010.00830.x. Bipolar Disord. 2010. PMID: 20636632 Review.
-
Serum levels of YKL-40 are increased in patients with psoriasis: a meta-analysis.Postgrad Med. 2019 Aug;131(6):405-412. doi: 10.1080/00325481.2019.1643634. Epub 2019 Jul 22. Postgrad Med. 2019. PMID: 31298974
Cited by
-
Inflammatory Effects and Regulatory Mechanisms of Chitinase-3-like-1 in Multiple Human Body Systems: A Comprehensive Review.Int J Mol Sci. 2024 Dec 15;25(24):13437. doi: 10.3390/ijms252413437. Int J Mol Sci. 2024. PMID: 39769202 Free PMC article. Review.
-
Higher Serum Galectin‑3 Levels Were Associated with More Severe Motor Performance in Parkinson's Disease.J Inflamm Res. 2024 Nov 4;17:8207-8214. doi: 10.2147/JIR.S491557. eCollection 2024. J Inflamm Res. 2024. PMID: 39525309 Free PMC article.
References
-
- Aalinkeel, R. , Mangum, C. S. , Abou‐Jaoude, E. , Reynolds, J. L. , Liu, M. , Sundquist, K. , Parikh, N. U. , Chaves, L. D. , Mammen, M. J. , Schwartz, S. A. , & Mahajan, S. D. (2017). Galectin‐1 reduces neuroinflammation via modulation of nitric oxide‐arginase signaling in HIV‐1 transfected microglia: A gold nanoparticle‐galectin‐1 “nanoplex” a possible neurotherapeutic? Journal of Neuroimmune Pharmacology, 12(1), 133–151. 10.1007/s11481-016-9723-4 - DOI - PubMed
-
- Akdemir, A. , Örsel, D. S. , İhsan, D. A. Ğ. , Türkçapar, M. H. , Işcan, N. , & Özbay, H. (1996). Hamilton depresyon derecelendirme ölçeği (HDDÖ)'nin geçerliliği‐güvenirliliği ve klinikte kullanımı. Psikiyatri Psikoloji Psikofarmakoloji Dergisi, 4(4), 251–259.
-
- Beumer, W. , Gibney, S. M. , Drexhage, R. C. , Pont‐Lezica, L. , Doorduin, J. , Klein, H. C. , Steiner, J. , Connor, T. J. , Harkin, A. , Versnel, M. A. , & Drexhage, H. A. (2012). The immune theory of psychiatric diseases: A key role for activated microglia and circulating monocytes. Journal of Leukocyte Biology, 92(5), 959–975. 10.1189/jlb.0212100 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials